Consultancy for NICE appraisal Consultation Document Response (GALLIUM trial)

Activity: Consultancy, spin-outs, CPD & licensingConsultancy & ServicesResearch

Description

I provided written expert advice for the company response to the ACD for Gazyvro, which led to NICE approval of Gazyvro in combination with chemotherapy in the first line management of follicular lymphoma
Period21 Sept 201729 Sept 2017
Work forF Hoffman - La Roche Ltd, Switzerland
Degree of RecognitionNational